CIK 0001526119 · Non-accelerated filer<br>Smaller reporting company
Verastem, Inc.
Sign in to watch- Ticker
- VSTM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- operating
- EIN
- 273269467
- Phone
- (781) 292-4200
- Business address
- 117 KENDRICK STREET, SUITE 500, NEEDHAM, MA, 02494
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $386,390
- in 4 filings, $386K under 10b5-1 plans
Net −$386,390. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-09-19 | Paterson Dan President and CEO | Sale | −183 | $9.84 | $2K | 87,343 |
| 2023-09-19 | Gagnon Robert E. Director | Sale | −130 | $9.84 | $1K | 46,626 |
| 2023-09-19 | Stuglik Brian M Director | Sale | −274 | $9.84 | $3K | 91,211 |
| 2023-09-18 | Paterson Dan President and CEO | Sale | −240 | $9.91 | $2K | 87,526 |
| 2023-09-18 | Gagnon Robert E. Director | Sale | −278 | $9.91 | $3K | 46,756 |
| 2023-09-18 | Stuglik Brian M Director | Sale | −478 | $9.91 | $5K | 91,485 |
| 2023-08-02 | Paterson Dan President and CEO | Grant or award | +50,000 | 87,766 | ||
| 2023-08-02 | Paterson Dan President and CEO | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2023-07-06 | Calkins Daniel Vice President of Finance | Sale | −5 | $8.02 | $40 | 8,694 |
| 2023-06-26 | Calkins Daniel Vice President of Finance | Sale | −26 | $8.17 | $212 | 8,422 |
| 2023-06-20 | Paterson Dan President and COO | Sale | −183 | $10.30 | $2K | 37,766 |
| 2023-06-20 | Gagnon Robert E. Director | Sale | −130 | $10.30 | $1K | 47,034 |
| 2023-06-20 | Stuglik Brian M Chief Executive Officer | Sale | −275 | $10.30 | $3K | 91,963 |
| 2023-06-16 | Paterson Dan President and COO | Sale | −244 | $9.92 | $2K | 37,949 |
| 2023-06-16 | Gagnon Robert E. Director | Sale | −283 | $9.92 | $3K | 47,164 |
| 2023-06-16 | Stuglik Brian M Chief Executive Officer | Sale | −487 | $9.92 | $5K | 92,238 |
| 2023-05-15 | Bunn Paul A. Director | Grant or award · Stock Option (right to buy) | +62,500 | 62,500 | ||
| 2023-05-15 | Rowinsky Eric K Director | Grant or award · Stock Option (right to buy) | +62,500 | 62,500 | ||
| 2023-05-15 | Kauffman Michael Director | Grant or award · Stock Option (right to buy) | +62,500 | 62,500 | ||
| 2023-05-15 | Kapur Anil Director | Grant or award · Stock Option (right to buy) | +62,500 | 62,500 |
Page 12 of 17 · 326 trades